Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001053

Drug Information
NameSargramostim    
SynonymsSargramostim; Leukine (TN); Sargramostim (genetical recombination) (JAN); D05803; 123774-72-1; Leukine; Sargramostim (genetical recombination); Sargramostim (USAN/INN)    
Trade NameLeukine    
CompanyBayer Pharmaceuticals Corporation    
IndicationBone marrow transplantationApproved    [1]
Therapeutic ClassImmunomodulatory Agents    
CAS NumberCAS 83869-56-1
FormularC639H1006N168O196S8    
PubChem Substance IDSID 47207464.    
TargetGranulocyte-macrophage colony-stimulating factor receptor alpha chainBinder[2][3]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Stem cell transplantation and hematopoietic growth factors. Curr Hematol Rep. 2002 Nov;1(2):103-9. To Reference
Ref 3Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy. Bone Marrow Transplant. 2002 Jan;29(2):159-64. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543